Yüklüyor......
Abciximab-induced acute profound thrombocytopenia postpercutaneous coronary intervention
Abciximab (c7E3 Fab) is one of the three potent intravenous glycoprotein IIb/IIIa receptor inhibitors (along with eptifibatide and tirofiban) that have shown significant positive outcomes when used in patients with intracoronary thrombus. However, major side effects have been reported with its use i...
Kaydedildi:
| Yayımlandı: | BMJ Case Rep |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5535180/ https://ncbi.nlm.nih.gov/pubmed/28710245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2017-221182 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|